Three scientists, Karl Deisseroth, Peter Hegemann, and Georg Nagel, were awarded the 2026 Nobel Prize in Physiology or Medicine for their groundbreaking work on light-gated ion channels and optogenetics, announced by the Nobel Assembly at Karolinska Institutet in Stockholm.
Optogenetics, a technique enabling the control of individual nerve cell activity in a living brain, has revolutionized neuroscience research worldwide, shedding light on the brain’s complexities. The laureates, Deisseroth, Hegemann, and Nagel, expressed their joy and gratitude for receiving the prestigious award together, emphasizing their camaraderie and shared accomplishments.
The Nobel Prize, accompanied by a prize amount of 12 million Swedish crowns, will be split among the three scientists. Deisseroth is affiliated with Stanford University, Hegemann with Humboldt University in Berlin, and Nagel with the University of Würzburg in Germany.
The impact of optogenetics extends beyond research laboratories, with ongoing clinical trials showing promise in restoring vision to individuals affected by retinitis pigmentosa, a vision disorder. Researchers envision further applications in enhancing cochlear implants for improved auditory nerve stimulation.
The journey to this groundbreaking discovery began decades ago, with Hegemann and Nagel’s early experiments on light-sensitive proteins in algae leading to the development of channelrhodopsin-2. Deisseroth’s subsequent work in rat nerve cells culminated in the inception of optogenetics, enabling precise control of neuronal activity using light stimulation.
The Nobel Prizes, established by Alfred Nobel, recognize individuals whose contributions benefit humanity. Nobel, a polymath known for inventing dynamite and his linguistic prowess, left a lasting legacy through these prestigious awards. The laureates will be formally honored on December 10, the anniversary of Nobel’s passing, marking a celebration of excellence in science and innovation.
